NYHA功能级I和II型野生型转甲状腺素型心肌病患者接受他法非地治疗的结局和疾病进展

IF 10.3 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Heart failure Pub Date : 2025-07-03 DOI:10.1016/j.jchf.2025.102549

Giulio Sinigiani MD , Giuseppe Damiano Sanna MD, PhD , Alberto Aimo MD, PhD , Aldostefano Porcari MD , Giacomo Bonacchi MD , Laura De Michieli MD, PhD , Paolo Milani MD, PhD , Giuseppe Vergaro MD, PhD , Giacomo Tini MD, PhD , Marco Baldan MD , Paola Martire MD , Alberto Beghini MD , Daniela Tomasoni MD , Giuseppe Palmiero MD , Paolo Ossola MD , Francesco Musca MD , Mattia Zampieri MD, PhD , Gabriele Guidi Colombi MD , Matteo Serenelli MD, PhD , Roberto Cemin MD , Alberto Cipriani MD

{"title":"NYHA功能级I和II型野生型转甲状腺素型心肌病患者接受他法非地治疗的结局和疾病进展","authors":"Giulio Sinigiani MD , Giuseppe Damiano Sanna MD, PhD , Alberto Aimo MD, PhD , Aldostefano Porcari MD , Giacomo Bonacchi MD , Laura De Michieli MD, PhD , Paolo Milani MD, PhD , Giuseppe Vergaro MD, PhD , Giacomo Tini MD, PhD , Marco Baldan MD , Paola Martire MD , Alberto Beghini MD , Daniela Tomasoni MD , Giuseppe Palmiero MD , Paolo Ossola MD , Francesco Musca MD , Mattia Zampieri MD, PhD , Gabriele Guidi Colombi MD , Matteo Serenelli MD, PhD , Roberto Cemin MD , Alberto Cipriani MD","doi":"10.1016/j.jchf.2025.102549","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 8","pages":"Article 102549"},"PeriodicalIF":10.3000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis\",\"authors\":\"Giulio Sinigiani MD , Giuseppe Damiano Sanna MD, PhD , Alberto Aimo MD, PhD , Aldostefano Porcari MD , Giacomo Bonacchi MD , Laura De Michieli MD, PhD , Paolo Milani MD, PhD , Giuseppe Vergaro MD, PhD , Giacomo Tini MD, PhD , Marco Baldan MD , Paola Martire MD , Alberto Beghini MD , Daniela Tomasoni MD , Giuseppe Palmiero MD , Paolo Ossola MD , Francesco Musca MD , Mattia Zampieri MD, PhD , Gabriele Guidi Colombi MD , Matteo Serenelli MD, PhD , Roberto Cemin MD , Alberto Cipriani MD\",\"doi\":\"10.1016/j.jchf.2025.102549\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14687,\"journal\":{\"name\":\"JACC. Heart failure\",\"volume\":\"13 8\",\"pages\":\"Article 102549\"},\"PeriodicalIF\":10.3000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC. Heart failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213177925004767\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213177925004767","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JACC. Heart failure CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

21.20

自引率

2.30%

发文量

164

期刊介绍： JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.